Conclusion With the completion of several cardiovascular and kidney outcome trials involving an increasing number of therapeutic agents, tremendous progress has been made in the management of individuals with type 2 diabetes and CKD
Why Personalization Matters: Dosage Accuracy: Your provider can adjust your semaglutide dose based on your results and side effects
This phenomenon, termed ingestion analgesia, has also been observed in animals 3,4,5,6
Using mouse models, this project investigates whether long-term treatment with a GLP-1 agonist can slow biological aging, preserve cognitive and physical function, and reduce markers of neurodegeneration
A host of questions emerged after this announcement
Answer: CJC-1295 and Ipamorelin are one option within a broader peptide and wellness platform